ANDA 71729, held by Gd Searle LLC. Clorazepate Dipotassium.
As of Nov 15, 2026, ANDA 71729 (Clorazepate Dipotassium), held by Gd Searle LLC, was first approved by FDA on Dec 18, 1987, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 18, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clorazepate Dipotassium15MG ยท capsule;oral | Clorazepate Dipotassium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
